Nextech Invest’s C4 Therapeutics CCCC Stock Holding History

Nextech Invest’s Portfolio CCCC Stock Details CCCC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-375,857	Closed	-$699K	–	12
2023 Q3	$699K	Hold	375,857	–	–	0.21%	14
2023 Q2	$1.03M	Hold	375,857	–	–	0.35%	13
2023 Q1	$1.18M	Hold	375,857	–	–	0.49%	12
2022 Q4	$2.22M	Hold	375,857	–	–	0.88%	14
2022 Q3	$3.3M	Hold	375,857	–	–	1.06%	14
2022 Q2	$2.83M	Hold	375,857	–	–	0.96%	14
2022 Q1	$9.12M	Hold	375,857	–	–	2.6%	12
2021 Q4	$12.1M	Buy	+375,857	New	+$14.9M	3.19%	10

Other funds holding CCCC

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Nextech Invest's CCCC Position: Q4 2023 in Review

Nextech Invest sold out of C4 Therapeutics (CCCC) in Q4 2023, closing a stake of 375,857 shares — an estimated $699K sold.

Nextech Invest first reported a position in CCCC in Q4 2021 and held it in 8 quarters. The position peaked at $12.1M in Q4 2021. 92 funds tracked by Wall St. Rank hold CCCC as of Q4 2023.

Nextech Invest reported no remaining C4 Therapeutics position as of Q4 2023 after selling out during the quarter.
Nextech Invest sold 375,857 C4 Therapeutics shares in Q4 2023, an estimated $699K.
Nextech Invest first reported a position in C4 Therapeutics in Q4 2021 and held it in 8 quarters.
Nextech Invest's C4 Therapeutics position peaked at $12.1M in Q4 2021.
92 funds tracked by Wall St. Rank held C4 Therapeutics as of Q4 2023.

Based on Nextech Invest's 13F filing for Q4 2023, filed 14 Feb 2024.